Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03498391Phase 2Suspended
Phase 2, randomised, open-label trial (2 arms), sponsored by University of Pennsylvania. Primary endpoint: Multi-sensory Evoked Responses. Started Jul 2018; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03498391.